- Home
- NTRA vs GEN Comparison
NTRA vs GEN Comparison
Compare NTRA & GEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRA
- GEN
- Stock Information
- Founded
- NTRA 2003
- GEN 1982
- Country
- NTRA United States
- GEN United States
- Employees
- NTRA N/A
- GEN N/A
- Industry
- NTRA Medical Specialities
- GEN Computer Software: Prepackaged Software
- Sector
- NTRA Health Care
- GEN Technology
- Exchange
- NTRA Nasdaq
- GEN Nasdaq
- Market Cap
- NTRA 21.5B
- GEN 18.2B
- IPO Year
- NTRA 2015
- GEN N/A
- Fundamental
- Price
- NTRA $171.86
- GEN $29.03
- Analyst Decision
- NTRA Strong Buy
- GEN Hold
- Analyst Count
- NTRA 16
- GEN 3
- Target Price
- NTRA $185.56
- GEN $28.33
- AVG Volume (30 Days)
- NTRA 1.2M
- GEN 5.1M
- Earning Date
- NTRA 08-07-2025
- GEN 07-31-2025
- Dividend Yield
- NTRA N/A
- GEN 1.72%
- EPS Growth
- NTRA N/A
- GEN 8.42
- EPS
- NTRA N/A
- GEN 1.03
- Revenue
- NTRA $1,831,000,000.00
- GEN $3,935,000,000.00
- Revenue This Year
- NTRA $19.92
- GEN $21.37
- Revenue Next Year
- NTRA $16.02
- GEN $4.73
- P/E Ratio
- NTRA N/A
- GEN $28.17
- Revenue Growth
- NTRA 51.50
- GEN 3.55
- 52 Week Low
- NTRA $92.14
- GEN $22.74
- 52 Week High
- NTRA $183.00
- GEN $31.72
- Technical
- Relative Strength Index (RSI)
- NTRA 66.42
- GEN 53.25
- Support Level
- NTRA $161.39
- GEN $29.18
- Resistance Level
- NTRA $169.17
- GEN $30.29
- Average True Range (ATR)
- NTRA 4.86
- GEN 0.54
- MACD
- NTRA 0.57
- GEN -0.08
- Stochastic Oscillator
- NTRA 90.95
- GEN 43.82
About NTRA Natera Inc.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
About GEN Gen Digital Inc.
Gen is a cybersecurity pure-play that offers security, identity protection, and privacy solutions to individual consumers. The firm's cyber safety offerings, via brands such as Norton, Avast, and LifeLock, have long maintained their positions as some of the most recognizable consumer-focused security and identity-protection products.